Vaccine-Induced Measles Virus-Specific T Cells Do Not Prevent Infection or Disease but Facilitate Subsequent Clearance of Viral RNA
ABSTRACT Infection with wild-type measles virus (MeV) induces lifelong protection from reinfection, and parenteral delivery of the live attenuated measles vaccine (LAV) also provides protection from measles. The level of neutralizing antibody is a good indicator of protection, but the independent ro...
Guardado en:
Autores principales: | , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
American Society for Microbiology
2014
|
Materias: | |
Acceso en línea: | https://doaj.org/article/4dc200c9250641129559bdc10995d0bb |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:4dc200c9250641129559bdc10995d0bb |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:4dc200c9250641129559bdc10995d0bb2021-11-15T15:45:12ZVaccine-Induced Measles Virus-Specific T Cells Do Not Prevent Infection or Disease but Facilitate Subsequent Clearance of Viral RNA10.1128/mBio.01047-142150-7511https://doaj.org/article/4dc200c9250641129559bdc10995d0bb2014-05-01T00:00:00Zhttps://journals.asm.org/doi/10.1128/mBio.01047-14https://doaj.org/toc/2150-7511ABSTRACT Infection with wild-type measles virus (MeV) induces lifelong protection from reinfection, and parenteral delivery of the live attenuated measles vaccine (LAV) also provides protection from measles. The level of neutralizing antibody is a good indicator of protection, but the independent roles of MeV-specific antibody and T cells have not been identified. In this study, macaques immunized with LAV through a nebulizer and a mouthpiece developed MeV-specific T-cell responses but not neutralizing antibodies. Upon challenge with wild-type MeV, these animals developed rashes and viremias similar to those in naive animals but cleared viral RNA from blood 25 to 40 days faster. The nebulizer-immunized animals also had more robust MeV-specific CD4+ and CD8+ T-cell responses than the naive animals after challenge, characterized by a higher number and better durability of gamma interferon (IFN-γ)-producing cells. Induction of MeV-specific circulating CD4+ and CD8+ T cells capable of producing multiple cytokines correlated with clearance of viral RNA in the nebulizer-immunized macaques. These studies demonstrated that MeV-specific T-cell immunity alone did not prevent measles, but T-cell priming enhanced the magnitude, durability, and polyfunctionality of MeV-specific T cells after challenge infection and correlated with more rapid clearance of MeV RNA. IMPORTANCE The components of vaccine-induced immunity necessary for protection from infection and disease have not been clearly identified for most vaccines. Vaccine development usually focuses on induction of antibody, but T-cell-based vaccines are also under development. The live attenuated measles vaccine (LAV) given subcutaneously induces both T cells and neutralizing antibody and provides solid protection from infection. LAV delivered to the upper respiratory tract through a nebulizer and mouthpiece induced a T-cell response but no neutralizing antibody. These T-cell-primed macaques demonstrated no protection from rash or viremia when challenged with wild-type MeV, but viral RNA was cleared more rapidly than in unimmunized animals. Thus, T-cell immunity did not protect from infection or acute disease but facilitated virus clearance during recovery. These studies demonstrate the importance and independent roles of T cells and antibody in protection and recovery from measles.Wen-Hsuan W. LinChien-Hsiung PanRobert J. AdamsBeth L. LaubeDiane E. GriffinAmerican Society for MicrobiologyarticleMicrobiologyQR1-502ENmBio, Vol 5, Iss 2 (2014) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Microbiology QR1-502 |
spellingShingle |
Microbiology QR1-502 Wen-Hsuan W. Lin Chien-Hsiung Pan Robert J. Adams Beth L. Laube Diane E. Griffin Vaccine-Induced Measles Virus-Specific T Cells Do Not Prevent Infection or Disease but Facilitate Subsequent Clearance of Viral RNA |
description |
ABSTRACT Infection with wild-type measles virus (MeV) induces lifelong protection from reinfection, and parenteral delivery of the live attenuated measles vaccine (LAV) also provides protection from measles. The level of neutralizing antibody is a good indicator of protection, but the independent roles of MeV-specific antibody and T cells have not been identified. In this study, macaques immunized with LAV through a nebulizer and a mouthpiece developed MeV-specific T-cell responses but not neutralizing antibodies. Upon challenge with wild-type MeV, these animals developed rashes and viremias similar to those in naive animals but cleared viral RNA from blood 25 to 40 days faster. The nebulizer-immunized animals also had more robust MeV-specific CD4+ and CD8+ T-cell responses than the naive animals after challenge, characterized by a higher number and better durability of gamma interferon (IFN-γ)-producing cells. Induction of MeV-specific circulating CD4+ and CD8+ T cells capable of producing multiple cytokines correlated with clearance of viral RNA in the nebulizer-immunized macaques. These studies demonstrated that MeV-specific T-cell immunity alone did not prevent measles, but T-cell priming enhanced the magnitude, durability, and polyfunctionality of MeV-specific T cells after challenge infection and correlated with more rapid clearance of MeV RNA. IMPORTANCE The components of vaccine-induced immunity necessary for protection from infection and disease have not been clearly identified for most vaccines. Vaccine development usually focuses on induction of antibody, but T-cell-based vaccines are also under development. The live attenuated measles vaccine (LAV) given subcutaneously induces both T cells and neutralizing antibody and provides solid protection from infection. LAV delivered to the upper respiratory tract through a nebulizer and mouthpiece induced a T-cell response but no neutralizing antibody. These T-cell-primed macaques demonstrated no protection from rash or viremia when challenged with wild-type MeV, but viral RNA was cleared more rapidly than in unimmunized animals. Thus, T-cell immunity did not protect from infection or acute disease but facilitated virus clearance during recovery. These studies demonstrate the importance and independent roles of T cells and antibody in protection and recovery from measles. |
format |
article |
author |
Wen-Hsuan W. Lin Chien-Hsiung Pan Robert J. Adams Beth L. Laube Diane E. Griffin |
author_facet |
Wen-Hsuan W. Lin Chien-Hsiung Pan Robert J. Adams Beth L. Laube Diane E. Griffin |
author_sort |
Wen-Hsuan W. Lin |
title |
Vaccine-Induced Measles Virus-Specific T Cells Do Not Prevent Infection or Disease but Facilitate Subsequent Clearance of Viral RNA |
title_short |
Vaccine-Induced Measles Virus-Specific T Cells Do Not Prevent Infection or Disease but Facilitate Subsequent Clearance of Viral RNA |
title_full |
Vaccine-Induced Measles Virus-Specific T Cells Do Not Prevent Infection or Disease but Facilitate Subsequent Clearance of Viral RNA |
title_fullStr |
Vaccine-Induced Measles Virus-Specific T Cells Do Not Prevent Infection or Disease but Facilitate Subsequent Clearance of Viral RNA |
title_full_unstemmed |
Vaccine-Induced Measles Virus-Specific T Cells Do Not Prevent Infection or Disease but Facilitate Subsequent Clearance of Viral RNA |
title_sort |
vaccine-induced measles virus-specific t cells do not prevent infection or disease but facilitate subsequent clearance of viral rna |
publisher |
American Society for Microbiology |
publishDate |
2014 |
url |
https://doaj.org/article/4dc200c9250641129559bdc10995d0bb |
work_keys_str_mv |
AT wenhsuanwlin vaccineinducedmeaslesvirusspecifictcellsdonotpreventinfectionordiseasebutfacilitatesubsequentclearanceofviralrna AT chienhsiungpan vaccineinducedmeaslesvirusspecifictcellsdonotpreventinfectionordiseasebutfacilitatesubsequentclearanceofviralrna AT robertjadams vaccineinducedmeaslesvirusspecifictcellsdonotpreventinfectionordiseasebutfacilitatesubsequentclearanceofviralrna AT bethllaube vaccineinducedmeaslesvirusspecifictcellsdonotpreventinfectionordiseasebutfacilitatesubsequentclearanceofviralrna AT dianeegriffin vaccineinducedmeaslesvirusspecifictcellsdonotpreventinfectionordiseasebutfacilitatesubsequentclearanceofviralrna |
_version_ |
1718427581410181120 |